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DBS in this patient and the procedure maybe an important
treatment consideration for patients who have treatment re-
fractory generalized action myoclonus of other origins such
as postanoxic action myoclonus and even some forms of
myoclonic epilepsies.
LEGENDS TO THE VIDEO
Segment 1. Preoperative video clip of the patient showing
frequent rest and action-exaggerated myoclonic jerks involving
head, neck, shoulder, proximal arm, and face; speech was jerky.
Torticollis and foot dystonia are also depicted in the video.
Segment 2. Postoperative video clip: myoclonic jerks, tor-
ticollis, and foot dystonia have almost completely disap-
peared. No myoclonus was observed even with activity;
speech and gait are normal.
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Psychogenic Movement Disorder Mimicking
RLS: A Case Report
Video
The restless legs syndrome (RLS) is a very common neuro-
logical disorder with prevalence between 5 and 10% of the
Caucasian population1 and diagnosis is predominantly made
by medical history according to the four essential criteria of
the International RLS Study Group (IRLSSG).2 In addition,
the levodopa test has a high diagnostic specifity and may
help to rule out the diagnosis in ambigious cases.3
Psychogenic movement disorder (PMD) is common in ev-
ery day neurological practice as well.4
We report a 47-year old Caucasian man with sleep disturban-
ces, fragmented night sleep, tiredness, and fatigue during the
day since several years. He reports prickling sensations in both
legs and an urge to move that occurs during rest mainly in the
evening but also during daytime. Because of these unpleasant
sensations he awakes about three times during the night and has
to go up and walk around. These symptoms are partially to
totally relieved by movements. Initially, they appeared sporadi-
cally, but at the time of investigation they occur every day. His
father had the same problems. Blood samples including ferritin
were normal. A mild obstructive sleep apnoea syndrome is
known. Under therapy with nasal CPAP, the respiratory distress
index was below five per hour sleep time but fragmented night
sleep and fatigue during day persisted. Because of a presumed
RLS he tried 100/25 mg levodopa/benserazide at three evenings
when maximal symptoms occurred without any beneficial effect.
The neurological examination was normal, and a polyneu-
ropathy was excluded by neurophysiological examinations.
The score of the Epworth sleepiness scale was 14, suggesting
increased daytime sleepiness. The score of the International
RLS Scale was 32, expressing very severe RLS symptoms.
Sleep laboratory diagnostic procedure excluded periodic leg
movements while awake (PLMW) and during sleep (PLMS) and
did not reveal any other pathological findings during sleep. Long
lasting, high and low frequent, irregular occurring bizarre move-
ments of both legs and arms only while awake and while lying
or sitting could be observed. These movements were told to
occur involuntarily and did not fulfil diagnostic criteria of
PLMW or PLMS.5 The present psychosomatic examination
showed no reference to depressive symptoms, but the patient’s
report of minor internal complaints (occasional heartburn/hyper-
cholesterinaemia) seemed to be exaggerated. His denial of wor-
ries and conflicts related to his psycho-social environment
seemed unrealistic. The psychosomatic evidence indicated a
deficiency in understanding emotions (alexithymic condition)
with a highly narrowed emotional oscillation and a primarily so-
matic expression of feelings and emotions.
In this case, the patient fulfilled all essential criteria for
diagnosing RLS. However, the patient did not response to the
levodopa test. This is not a basic requirement for diagnosis of
RLS and might be even common.6 Sleep laboratory investiga-
tions in patients who fulfil all essential criteria of RLS are not
required according to the German guidelines ‘‘Polysomnog-
raphy and RLS."7 Nevertheless, it could be reasonable in some
atypical and doubtful cases, because patients who do not
respond to conventional treatment and have no PLMW or
PLMS might represent a distinct population from classical
RLS and show even higher levels of psychiatric comorbidity
like anxiety and depression as known in classical RLS.8
In our case, we were able to detect long lasting bizarre move-
ments of both legs and sometimes of the arms only while awake,
which are for some reasons not corresponding with the move-
ments of RLS patients. First, our patient was able to sit or lie for
hours without the urge to go up and move around, which is
atypically for RLS patients with severe symptoms. Furthermore,
he affirmed that the movements we saw during the day tests
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(Maintenance of Wakefulness Test) and during the neurophysio-
logical examination (see video) is involuntary and are not differ-
ent from the movements he is suffering at home. However, he
could not say that certain motion patterns relief his complaints,
whereas RLS patients who show sometimes bizarre movements
can point out this very well. Moreover, we saw an abrupt onset
of these movements triggered by sensitive stimuli like mild elec-
tric current for analysing nerve conduction and also an abrupt
ending when the patient got up.
Summarizing, the patient fulfilled all the anamnestic crite-
ria for diagnosing RLS but showing atypical movements in
the videometry. In contrast, the movements the patient
denoted as involuntary were inconsistent to any somatic dis-
ease. According to diagnostic criteria by Fahn and William9
and Shill and Gerber,10 we diagnosed a clinically established
PMD due to inconsistence with organic disease, excessive fa-
tigue and exposure to a disease model (the father was prob-
ably affected by RLS and the patient was intensively engaged
in an RLS self help group). Although PMD can mimic the
full range of abnormal organic involuntary movements, ‘‘psy-
chogenic RLS and PLMW’’ has, to the best of our knowl-
edge, not been described before. We emphasize the impor-
tance of sleep laboratory examinations with videometry in
patients fulfilling the essential criteria of RLS but do not ben-
efit from dopaminergic therapy.
LEGENDS TO THE VIDEOS
Video 1 and 2: First and second night in sleep laboratory
during wake with irregularly bizarre short and long lasting
movements of the lower and upper limbs.
Video 3: This video shows the movements during the
Maintenance of Wakefulness Test.
Video 4 and 5: Mild electric current during electrophysio-
logical examination provoked movements of the legs and
relief during walking.
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Slow Orthostatic Tremor in Multiple Sclerosis
Video
Although several forms of tremor are common in multiple
sclerosis (MS), orthostatic tremor (OT) has not been
reported.1
A 38-year-old woman, diagnosed with clinically definite
relapsing remitting MS at the age of 27, presented following
initial improvement from a relapse affecting ambulation,
complaining of tremor affecting her legs associated with an
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FIG. 1. Radiology and clinical neurophysiology. (A) MRI brain. Axial FLAIR sequence showing left middle cerebellar peduncle (brachium pon-
tis) lesion consistent with demyelination. (B) Equivalent axial gadolinium enhanced T1-weighted MRI sequence. Note that the area of active
inflammation (indicated by arrow head) co-localises with the lesion shown in A. (C) Tremor power spectrum (data obtained from accelerometer
attached to the left patella during stance). (D) Rectified EMG recorded from left tibialis anterior (L TA), left gastrocnemius-soleus (L GS), left
vastus lateralis (L VL) and right vastus lateralis (R VL) muscles while the patient was standing. Each trace represents one second of data. EMG
bursts have a duration of approximately 100 ms (see timebase, top right). Voltage calibration bars are shown to the left of each trace. (E) EMG
power spectra (expressed as a fraction of total power) derived from EMG recordings illustrated in (A) (data length 340s). (F) Intermuscular coher-
ence spectra. Muscle pairs used to calculate coherence spectra are indicated above each plot. Data points above the dashed lines indicate signifi-
cant coherence (P < 0.05)2 (G) Phase resetting plot. Each point represents the effects of one tendon tap stimulus delivered to the patella tendon.
Abscissa represents phase of 4 Hz oscillation in patella acceleration prior to a tap and ordinate represents phase one cycle following stimulation;
phase in both cases is expressed as a fraction of an oscillation cycle. Linear dependence indicates that the tap stimulus did not affect the phase of
ongoing tremor.
intense feeling of unsteadiness. The tremor was not present
when sitting but appeared upon standing (see video). It was
reduced but not relieved by walking. Neurological examina-
tion demonstrated increased tone in the legs, ankle clonus,
pyramidal weakness in the left leg (MRC grade 4), symmetri-
cal hyperreflexia, extensor plantar responses, mild left upper
limb dysmetria, mild bilateral heel-shin ataxia, impaired pro-
prioception at the hallux bilaterally and absent vibration
sense to the knee. These examination findings had remained
stable for several years (outside of acute relapses) and
until she developed OT had not prevented independent
ambulation.
MRI showed active disease with several periventricular
lesions in frontal and parietal cortex, and one lesion within
the left brachium pontis (Fig. 1A), which enhanced with gad-
olinium (Fig. 1B).
Electrophysiology showed no evidence of axial or appen-
dicular tremor while seated, but as the patient stood tremor
appeared in the legs and trunk. The tremor power spectrum
obtained from an accelerometer affixed to the left patella
(Fig. 1C) showed a dominant peak at 4 Hz and a smaller
sub-harmonic at 8 Hz. Raw rectified EMG recorded using
adhesive electrodes from left tibialis anterior (gain 500–
5000; band pass filtered 30 Hz–2 kHz; 5 kHz digitization)
whilst standing contained four 100ms bursts of EMG per sec-
ond (Fig. 1D). Frequency domain analysis (see normalized
power spectra in Fig. 1E) confirmed that the dominant fre-
quency was 4 Hz. In the left gastrocnemius-soleus and tibi-
alis anterior power spectra there were small additional 8–15
Hz sub-peaks. Coherence analysis (see Refs. 2 and 3) con-
firmed that there was significant unilateral and bilateral EMG-
EMG coherence not only at tremor frequency but also in the 8–
12 Hz and 13–18 Hz ranges, suggesting that other common
frequencies might also be driving lower limb tremor (Fig. 1F).
The effects of patella tendon stimulation on OT were also
investigated (Fig. 1G). The linear relationship between tremor
phase before and after a tendon tap confirmed that this form of
muscle afferent stimulation could not reset the phase of the
tremor, as previously described in slow4 and fast OT.5,6
Pharmacological treatment (i.e., clonazepam, levetirace-
tam, levodopa, gabapentin) was either ineffective or produced
intolerable side effects.
Orthostatic tremor (OT) is a rare form of action tremor
affecting the legs and trunk. It appears on standing, is associ-
ated with a profound and disabling sense of unsteadiness and
is relieved by sitting, walking or the use of a support. Two
types of OT are recognized: fast OT, characterised by bursts
of muscle activity at 13–18 Hz7–9; and slow OT,4,10 with a
frequency of 3–8 Hz.
Slow OT was first described in 1986 in a family with
essential tremor.10 Subsequently it has been described in
patients with Parkinson’s disease and Parkinsonism,11–13 and
in one patient two months after resection of a cavernoma
involving the right brachium pontis14 (cf. Fig. 1A,B). Idio-
pathic slow OT, in the absence of primary or associated neu-
rological disease has also been described.4
In slow OT EMG recordings from leg, trunk and arm
muscles demonstrate regular 70–120 ms bursts of activity in
the 4-6 Hz range.13 Coherence analysis reveals powerful cou-
pling between EMG recorded from lower limb, upper limb
and axial muscles both unilaterally and bilaterally, at tremor
frequency, which is absent in controls under normal condi-
tions15 and patients with orthostatic myoclonus.13 Treatment
with clonazepam is reportedly helpful; if there is associated
parkinsonism anecdotal evidence supports the use of L-dopa,
dopamine receptor agonists or trihexyphenidyl, with or with-
out clonazepam.16,17
Although OT has not previously been described in MS,
the spastic-ataxic gait sometimes encountered in MS can be
mistaken for OT.18 This is partly because of the subjective
sense of unsteadiness, but also because the frequency of clo-
nus (4 Hz)19 can resemble tremor. Clonus, which is easily
reset by stimulating muscle afferents,20 did not contribute to
the OT observed in our patient because her tremor could not
be entrained by tendon vibration (see Fig. 1G).
LEGENDS TO THE VIDEO
A. Standing. Initially the patient is seated and there is no
lower limb or axial tremor. As she stands up marked axial
and lower limb tremor appears. B. Walking. As the patient
walks, with the aid of two sticks, the tremor appears to
improve. However, there was no subjective change in the
sensation of unsteadiness. C. Lower limb examination. The
patient demonstrates evidence of mild heel-shin ataxia, which
is worse on the left. D. Co-contraction. While supine the
patient was asked to raise her legs with her feet in plantar
flexion and to co-contract her leg muscles. During this
manoeuvre there is no visible tremor (tremor can only be
detected with accelerometry). E. Upper limb examination.
Assessment of tremor in the upper limbs only demonstrated
mild terminal tremor on the left. F. Eye movements. Only
smooth pursuit was tested, which was normal.
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Acute Urinary Retention in Two Patients After
Subthalamic Nucleus Deep Brain Stimulation
(STN-DBS) for the Treatment of Advanced
Parkinson’s Disease
In advanced Parkinson’s disease (PD) most patients develop
severe fluctuations of mobility after long-term treatment with
Levodopa.1 In medically refractory motor fluctuations deep
brain stimulation (DBS) of the subthalamic nucleus (STN) is
an effective treatment to control these complications.2
Besides motor symptoms, patients with PD often complain of
urinary symptoms such as urgency, frequency, and inconti-
nence.3 STN-DBS has proven to improve urinary function by
increasing bladder capacity and reducing urgency.4 Recent
data from PET studies suggest that this effect may result
from facilitated processing of afferent bladder information
thereby improving bladder function in these patients by
reducing pollakisuria and increasing bladder capacity.5 How-
ever, there are no data in current literature describing deterio-
rated bladder function after STN-DBS in patients with preop-
erative normal bladder function. We report on two patients
who experienced acute urinary retention for several weeks af-
ter STN-DBS.
Two patients underwent STN-DBS for the treatment of
motor symptoms in advanced PD. The patient characteristics
are described in Table 1. STN-DBS was performed after
fusion of the planning-MRI (2 days preoperatively) with a
stereotactic cranial CT (operating day). Multiple microelec-
trode recordings were performed intraoperatively before test-
stimulation via the macro-tip of the recording electrode. The
STN-DBS-electrode was implanted in the trajectory with the
widest therapeutic window (low threshold for improvement
of akinetic-rigid symptoms and high threshold for stimula-
tion-induced side-effects).
Both patients reported significant improvement of motor
symptoms and quality of life postoperatively. After removing
the transurethral catheter on the second postoperative day,
both patients developed acute urinary retention. In the urody-
namic examination under active DBS system, both patients
stated no filling sensation and no desire to void despite an
instilled volume of 600 mL and there was no detrusor activ-
ity. The compliance of the bladder was normal (>25 mL/cm
H2O). The urodynamic evaluations are performed in a strictly
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